Goodsurance

Drug prices & Part D

Spread your Medicare drug costs by month

A free Medicare option lets you pay your prescription costs in monthly installments instead of a big hit at the pharmacy. With the 2026 out of pocket cap at $2,100, it can soften a January spike.

By the Goodsurance editorial teamJune 29, 2026

There is a Medicare option that many people have never heard of, and it can help most if you have a large prescription bill early in the year. It is called the Medicare Prescription Payment Plan. Every Part D drug plan has been required to offer it since 2025, it costs nothing to join, and it is voluntary. Here is how it works. Instead of paying a big amount at the pharmacy counter when you fill an expensive prescription, you pay nothing at the register and the plan spreads your share into capped monthly payments billed across the rest of the year. It does not lower your total drug costs or change your coverage; it only changes the timing, turning one painful month into smaller steady amounts. This matters more in 2026 because of how Part D now works. Your out of pocket spending on covered drugs is capped at $2,100 for the year, and many people hit a large share of that early, for example when an expensive medication refills in January. The payment plan is built for exactly that situation. Who should think about it? People with high cost drugs who would feel a big one time charge, and who would rather budget it monthly. Who can usually skip it? People with low drug costs, since spreading a small amount adds little. People enrolled in 2025 were carried into 2026 automatically, and anyone can opt in at any time by contacting their plan. As you look ahead to the fall enrollment season, it is worth knowing this lever exists. The pointed framing about whether the timing fix goes far enough on drug affordability routes to my65checklist; here the job is to make sure the tool is on your radar.

In plain words

Here is a Medicare option many people have never heard of. It is called the Medicare Prescription Payment Plan. It can help if you have a big drug bill early in the year. Every Part D drug plan must offer it. It is free to join, and you choose whether to use it. Here is how it works. Instead of paying a lot at the pharmacy when you fill a costly prescription, you pay nothing there. Your plan spreads your share into smaller monthly bills over the rest of the year. It does not lower your total cost. It only changes when you pay. This helps more in 2026. Your out of pocket cost for covered drugs is capped at $2,100 for the year. Many people reach a big part of that early. So a monthly plan can soften that first hit. Who should think about it? People with costly drugs who do not want one big charge. Who can skip it? People with small drug costs. If you used it in 2025, you were kept in for 2026. Anyone can join any time by calling their plan.

Source: Medicare.gov
Read at the source →

More news

Other stories on what is moving in Medicare.

Drug prices & Part D

KFF: Medicare Advantage Drug Plans Received Over 600 Dollars Per Member in Rebates That Standalone Drug Plans Cannot Access

A KFF analysis explains the structural payment asymmetry that makes it harder for standalone Part D plans to compete on drug premiums, as the number of those plans hits record lows ahead of open enrollment.

August 8, 2026

Drug prices & Part D

Bipartisan Senate Bill Would Preserve Drug Discounts for Safety-Net Hospitals and Shut Down a Rebate Pilot

Six senators from both parties introduced the SUSTAIN 340B Act on August 5, proposing to protect point-of-purchase drug discounts for safety-net providers while adding new transparency and audit requirements.

August 6, 2026

Drug prices & Part D

CMS Counted a 2020 Reclassification Date for Creon, Delaying Medicare Price Talks by Years, Report Says

Public Citizen says CMS allowed AbbVie to use the date Creon was reclassified as a biologic rather than its original FDA approval date, pushing the drug's eligibility for Medicare price negotiation years into the future.

August 5, 2026

Drug prices & Part D

Medicare Part D Deductible Rises to 700 Dollars and Out-of-Pocket Drug Cap Reaches 2,400 Dollars for 2027

The Inflation Reduction Act tied the Medicare Part D annual deductible and catastrophic spending limit to drug cost growth, and both parameters rise again for 2027, continuing an upward pattern as specialty and GLP-1 drug spending climbs across the program.

August 4, 2026

Drug prices & Part D

Medicare and Drug Manufacturers Are Holding Negotiation Meetings This Summer on 15 High-Cost Drugs, With Final Prices Due by November

The third cycle of Medicare drug price negotiations is in its most active phase, with CMS and participating manufacturers in sessions that must conclude by November 1, 2026, to set maximum fair prices on cancer, HIV, and other specialty drugs taking effect in 2028.

August 3, 2026

Drug prices & Part D

CMS Confirms the 2027 Medicare Part D Base Premium at 41 Dollars and 33 Cents as a Federal Stabilization Subsidy for Drug Plans Ends

The confirmed base premium equals the maximum 6 percent annual increase the Inflation Reduction Act allows, but consumer advocates warn that actual plan-level premiums, which are set above that floor, are likely to climb sharply once a temporary federal subsidy expires at year-end.

July 30, 2026